InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Browse the detailed record of transactions filed by Huang Dennis Karl, Vice-Président Exécutif et Responsable des Opérations Technologiques. Director active across 1 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 5 disclosures have been recorded. Total volume traded: €311k. The latest transaction was disclosed on 1 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€192,0923,234 shares@ €59.39770.0078% mcap61.8% of flow
Common Stock
SEC:0001209191-22-015815:0·
€25,060358 shares@ €69.99950.0010% mcap42.3% of flow
Common Stock
SEC:0001209191-21-060759·
€25,060358 shares@ €69.99950.0010% mcap8.1% of flow
Common Stock
SEC:0001209191-21-060759:0·
€34,193363 shares@ €94.19520.0014% mcap57.7% of flow
Common Stock
SEC:0001209191-21-031390·
€34,193363 shares@ €94.19520.0014% mcap11.0% of flow
Common Stock
SEC:0001209191-21-031390:0·
5 of 5 declarations
About Huang Dennis Karl
Dennis Karl Huang serves as Executive Vice President and Chief Tech Ops Officer of Ultragenyx Pharmaceutical Inc. He oversees the company's technological operations and plays a key role in developing innovative solutions. His technical expertise is an asset for Ultragenyx in the pharmaceutical sector.
